Newsfeeds - Spark Newswire

1 minute read

Athenex Inks Commercialization Pacts For Tirbanibulin In Australia, New Zealand

Today, 11:08 AM

Athenex Inc (NASDAQ:ATNX) has entered into licensing agreements and partnerships with Seqirus Pty Ltd, a subsidiary of CSL Limited, and AVIR Pharma Inc to commercialize…

ATNX

2 minute read

Athenex Announces Licensing Agreements With Seqirus Pty And AVIR Pharma For Tirbanibulin; Seqirus To Have Exclusive License In Australia And New Zealand, AVIR To Have Exclusive License In Canada

By Bill Haddad

Today, 11:08 AM

Athenex, Inc., (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that

ATNX

3 minute read

FDA
News

Athenex Reports European Commission Approval Of Klisyri For Topical Treatment Of Actinic Keratosis

By Benzinga Newsdesk

Today, 11:08 AM

ATNX

1 minute read

News

‘Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors’ – ClinicalTrials.gov

By Benzinga Newsdesk

Today, 11:08 AM

Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov

ATNX

2 minute read

FDA
News

Athenex Highlights Data For 2 Poster Presentations At American Society Of Clinical Oncology

By Benzinga Newsdesk

Today, 11:08 AM

Data from oral docetaxel phase I pharmacokinetic study shows oral administration can achieve exposure comparable to IV docetaxel Post-hoc subgroup efficacy analysis based on updated tumor subtypes in the oral

ATNX

5 minute read

Uncategorized

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

By Shanthi Rexaline

Today, 11:08 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)

ACHL

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 11:08 AM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL

5 minute read

Uncategorized

70 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:08 AM

Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.

ADMP

32 minute read

Uncategorized

Earnings Scheduled For May 6, 2021

By Benzinga Insights

Today, 11:08 AM

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.

AAOI